- Corticosteroids Cause Unnecessary Bone Loss. // Tufts University Health & Nutrition Letter;Jul2000, Vol. 18 Issue 5, p1
States that patients receiving long-term corticosteroid therapy may be subject to needless bone loss. Diseases being treated with corticosteroid drugs; Finding of researchers at the Medical College of Virginia when they surveyed patients taking prednisone everyday; Pieces of advice to prevent...
- Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Shrewsbury, Stephen; Pyke, Stephen; Britton, Mark // BMJ: British Medical Journal (International Edition);05/20/2000, Vol. 320 Issue 7246, p1368
Features a study which aimed to examine the benefits of adding salmeterol compared with increasing dose of inhaled corticosteroids in symptomatic asthma. Methodology of the study; Results and discussion; Conclusions.
- A Review of the Role of Inhaled Corticosteroids in the Treatment of Acute Asthma. Chipps, Bradley E.; Chipps, Donna R. // Clinical Pediatrics;Apr2001, Vol. 40 Issue 4, p185
Summary: Systemic corticosteroids (CSs) are generally accepted as treatment for acute exacerbations of asthma. In contrast, inhaled corticosteroids (ICs) have been used for the long-term management of asthma but are not widely accepted for the treatment of asthma exacerbations. The onset of...
- What is the optimal dose of inhaled corticosteroids in adult asthma? Chapman, Kenneth R. // Patient Care;2/1/1997, Vol. 31 Issue 2, p24
Focuses on the use of prescribe inhaled corticosteroids in higher doses to manage adult asthma. What is the optimal dose of inhaled corticosteroids in asthma; Explanations to be considered if patients with asthma do not respond well to dosages of inhaled corticosteroid under 1,000 a day; Why...
- Review: Adding antileukotrienes to inhaled corticosteroids reduces exacerbations in symptomatic chronic asthma. Rees, P. John // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p99
Comments on a study which investigated the addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Results; Treatment which reduces the rate of exacerbations that require systemic corticosteroids; Effects of inhaled corticosteroids on asthma.
- What are the Alternatives to Increasing Inhaled Corticosteroids for the Long Term Control of Asthma? Flood-Page, P.; Barnes, N.C. // BioDrugs;2001, Vol. 15 Issue 3, p185
The Global Initiative for Asthma (GINA) guidelines stated the therapeutic goals for the management of asthma and, through a stepwise approach to treatment, defined the various grades of asthma severity and the therapeutic options available to the clinician at each step. This article considers...
- Inhaled vs. Systemic Corticosteroids in Asthma. Miller, Karl E. // American Family Physician;3/1/2003, Vol. 67 Issue 5, p1107
Presents a study that hypothesized that the use of high-dosage, inhaled corticosteroids in hospitalized asthma patients could be as well tolerated and effective as oral corticosteroids. Use of systemic corticosteroids in the treatment of hospitalized asthma patients; Advantages of using inhaled...
- Effects of reducing or discontinuing inhaled budenoside in patients with mild asthma. Schuster, Nancy B. // Physical Therapy;Apr1995, Vol. 75 Issue 4, p332
Presents an abstract of a study entitled `Effects of Reducing or Discontinuing Inhaled Budenoside in Patients With Mild Asthma,' by T. Haahtela, M. Jarvinen et al, published in the `New England Journal of Medicine.' Effect of inhaled costicosteroid on mild asthma.
- Systemic safety of fluticasone furoate/vilanterol combination. Lipworth, Brian; Busse, William W.; Andersen, Leslie // Thorax;Dec2013, Vol. 68 Issue 12, p1164
A letter to the editor related to an article on the safety of fluticasone furoate/vilanterol combination in asthma by W.W. Busse, P.M. O'Byrne and E.R. Bleecker in the 2013 issue is presented.